Inventor · disambiguated record
Wan-Heng Wang
Also filed as: WANG WAN · WANG WAN-HENG
14 granted patents·19 pending applications·113 citations·filing 1998–2016
91Inventor score
Top patents by PatentIndex Score
33 records- 0195US7947660B2RNAi-mediated inhibition of frizzled related protein-1 for treatment of glaucomaALCON INC·Filed 2006·Granted May 24, 2011·31 cites·18 claims
- 0294US8173617B2RNAi-mediated inhibition of frizzled related protein-1 for treatment of glaucomaCLARK ABBOT F·Filed 2011·Granted May 8, 2012·31 cites·17 claims
- 0383US7662389B2Use of serum amyloid A gene in diagnosis and treatment of glaucoma and identification of anti-glaucoma agentsALCON INC·Filed 2006·Granted Feb 16, 2010·5 cites·2 claims
- 0482US7598288B2Inhibitors of glycogen synthase kinase-3 (GSK-3) for treating glaucomaALCON INC·Filed 2002·Granted Oct 6, 2009·17 cites·19 claims
- 0578US7807363B2Superoxide dismutase-2 expression for glaucoma diagnosisALCON RES LTD·Filed 2007·Granted Oct 5, 2010·5 cites·8 claims
- 0676US9102763B2Controlled release of ocular biopharmaceuticals using bioresponsive protein polymersMACKAY JOHN ANDREW·Filed 2012·Granted Aug 11, 2015·6 cites·15 claims
- 0770US2009226425A1Diagnostics and Therapeutics For GlaucomaALCON INC·Filed 2009·Application pending·0 cites
- 0868US7357931B2Use of serum amyloid a gene in diagnosis and treatment of glaucoma and identification of anti-glaucoma agentsALCON INC·Filed 2004·Granted Apr 15, 2008·5 cites·1 claims
- 0963US2014357692A1RNAi Inhibition of Serum Amyloid A For Treatment of GlaucomaNOVARTIS AG·Filed 2014·Application pending·0 cites
- 1063US2010113481A1Use of serum amyloid a gene in diagnosis and treatment of glaucoma and identification of anti-glaucoma agentsALCON RES LTD·Filed 2009·Application pending·0 cites
- 1161US2013123337A1RNAi Inhibition of Serum Amyloid A For Treatment of GlaucomaNOVARTIS AG·Filed 2012·Application pending·0 cites
- 1261US2010063052A1Use of serum amyloid a gene in diagnosis and treatment of glaucoma and identification of anti-glaucoma agentsALCON INC·Filed 2009·Application pending·0 cites
- 1360US2006172961A1RNAi inhibition of serum amyloid a for treatment of glaucomaALCON INC·Filed 2005·Application pending·0 cites
- 1459US9040494B2RNAi-mediated inhibition of frizzled related protein-1 for treatment of glaucomaCLARK ABBOT F·Filed 2012·Granted May 26, 2015·0 cites·16 claims
- 1559US7033755B2Diagnostics and therapeutics for glaucomaUNIV IOWA RES FOUND·Filed 2001·Granted Apr 25, 2006·2 cites·3 claims
- 1659US2012122961A1RNAi Inhibition of Serum Amyloid A For Treatment of GlaucomaCLARK ABBOT F·Filed 2012·Application pending·0 cites
- 1758US9550994B2RNAI-mediated inhibition of frizzled related protein-1 for treatment of glaucomaARROWHEAD RES CORP·Filed 2015·Granted Jan 24, 2017·0 cites·8 claims
- 1858US6723514B2Compositions and methods for directly and rapidly analyzing the biochemical components of microorganismsBIOCHAIV INST INC·Filed 2001·Granted Apr 20, 2004·1 cites·14 claims
- 1958US2009312390A1Inhibitors of glycogen synthase kinase-3 (gsk-3) for treating glaucomaALCON INC·Filed 2009·Application pending·0 cites
- 2058US2017073681A1RNAi-Mediated Inhibition of Frizzled Related Protein-1 for Treatment of GlaucomaARROWHEAD PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 2157US2009036371A1Use of Serum Amyloid A Gene in Diagnosis and Treatment of Glaucoma and Identification of Anti-Glaucoma AgentsALCON INC·Filed 2008·Application pending·0 cites
- 2256US7879006B2Injection aid for anterior juxtascleral depotALCON RES LTD·Filed 2009·Granted Feb 1, 2011·1 cites·4 claims
- 2356US7807355B2Diagnostics and therapeutics for glaucomaALCON INC·Filed 2006·Granted Oct 5, 2010·0 cites·11 claims
- 2456US2011054008A1RNAi Inhibition of Serum Amyloid A For Treatment of GlaucomaALCON INC·Filed 2010·Application pending·0 cites
- 2556US2015225720A1RNAi Inhibition of Serum Amyloid A For Treatment of GlaucomaNOVARTIS AG·Filed 2015·Application pending·0 cites
- 2654US2010152279A1RNAi Inhibition of Serum Amyloid A For Treatment of GlaucomaALCON INC·Filed 2010·Application pending·0 cites
- 2753US2005164907A1Diagnosis and treatment of glaucoma and methods for discovering new glaucoma therapeutic agents based on the wnt/planar cell polarity (pcp) signaling pathwayFiled 2003·Application pending·0 cites
- 2853US2006154981A1Method of reducing intraocular pressure and treating glaucomaALCON INC·Filed 2006·Application pending·0 cites
- 2952US2006134171A1Agents which regulate, inhibit, or modulate the activity and/or expression of formyl peptide receptors as a unique means to both lower intraocular pressure and treat glaucomatous retinopathies/optic neuropathiesALCON INC·Filed 2005·Application pending·0 cites
- 3051US2012064532A1Use of Serum Amyloid A Gene in Diagnosis and Treatment of Glaucoma and Identification of Anti-Glaucoma AgentsCLARK ABBOT F·Filed 2011·Application pending·0 cites
- 3149US2018094137A1Compositions and methods for the delivery of drugs to the ocular surface by contact lensesUNIV VIRGINIA PATENT FOUNDATION·Filed 2014·Application pending·0 cites
- 3244US6265164B1Compositions and methods for directly and rapidly analyzing the biochemical components of microorganismsBIOCHAIN INST INC·Filed 1998·Granted Jul 24, 2001·9 cites·14 claims
- 3344US2005170430A1Diagnosis and treatment of glaucoma and methods for discovering new glaucoma therapeutic agents based on the wnt/ca2+ signaling pathwayFiled 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Wan-Heng Wang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →